ISMPP Highlights
Recent ISMPP Member Publications and Presentations
ISMPP is pleased to share several recent publications and presentations by Society members. We encourage our members to publish and present research and information related to publishing practices to advance the medical publications profession, and improve standards and best practices…
Keynote Speakers Present on Cutting-Edge Topics at ISMPP’s 13th Annual Meeting
ISMPP is pleased to introduce its distinguished keynote speakers for our 13th Annual Meeting, May 1-3, 2017, at the Gaylord National Resort & Convention Center, National Harbor, MD, USA. The enlightening keynote presentations will address various cutting-edge topics in medical publications, including…
Transparency Matters – Take the Transparency Pledge!
Transparency Matters is a call to action launched by Medical Publishing Insights & Practices (MPIP), designed to raise awareness, provide resources, and improve the quality and transparency in reporting the results of industry-sponsored research. Similar to ISMPP, Transparency Matters seeks to…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
A New Age of Transparency: Do We Fully Understand the Implications?
Over the last few years, requirements for clinical trial transparency and data reporting have become more extensive to help patients and health care practitioners (HCPs) better understand the drugs they are taking or prescribing in clinical trials, with a focus on increasing trust and confidence in regulatory decisions on medicines. Publication professionals within sponsor companies must…
ICMJE Releases Highly Anticipated Data Sharing Requirements
The International Committee of Medical Journal Editors (ICMJE), which is comprised of various member journals including the New England Journal of Medicine (NEJM) and The Lancet, just published its highly anticipated data sharing requirements on June 6, 2017. These new requirements are subsequent to the ICMJE’s initial clinical trial data sharing proposal published in January 2016…
The Truth, the Whole Truth, or “About Half” of the Truth: AllTrials and TrialsTracker
Criticism of pharmaceutical industry sponsored clinical trials tends to fall into two main areas, summed up by sentences such as “About half of all randomized clinical trials are never published, and the other half is often published selectively” – results disclosure and selective reporting. In the current climate of calls for improved clinical trials transparency…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL SCENARIO: Presenting Author Changes Slides Just Before Oral Presentation
You are a company publication professional and have been supporting authors to develop an oral presentation for a scientific congress. The content is agreed upon and approved by authors prior to the start of the congress. Both sponsor and medical writing agency colleagues are onsite to provide support, and it was agreed that the presenting author would upload the slides to the system…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals